A carregar...
Improved anti-tumor activity and safety of interleukin-13 receptor targeted cytotoxin by systemic continuous administration in head and neck cancer xenograft model.
BACKGROUND: IL-13 receptor (IL-13R) targeted cytotoxin, IL13-PE38QQR, has been shown to have very potent anti-tumor activity to IL-13R-expressing head and neck tumor cells in vitro and in vivo. However, its effect is limited in aggressive tumors. To further improve the anti-tumor activity and safety...
Na minha lista:
Main Authors: | , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2002
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2040009/ https://ncbi.nlm.nih.gov/pubmed/12435859 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|